NCT00496730View on ClinicalTrials.gov

A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

256

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Hypercholesterolemia

Interventions

DRUG

simvastatin (+) ezetimibe

simvastatin (+) ezetimibe 10/20 mg ; tablet, once daily, 8 Weeks

DRUG

Comparator: atorvastatin

atorvastatin 10 mg; tablet, once daily, 8 Weeks

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00496730 - A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED) | Biotech Hunter | Biotech Hunter